Glycopyrrolate 0.2 MG/ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJZJ1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,385
Award facts
- Contract value 100% obligated
- $2,385.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for glycopyrrolate 0.2 mg/ml vial 20ml, with a ceiling value of $2,385.12.
The order was issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL.
Quick answers
Who was awarded contract SPE2DR26FJZJ1?
SPE2DR26FJZJ1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 6, 2026.
How much is contract SPE2DR26FJZJ1 worth?
The government has obligated $2,385 on SPE2DR26FJZJ1.
Is contract SPE2DR26FJZJ1 an order under another contract?
Yes. SPE2DR26FJZJ1 is a delivery order under SPE2DR25D9340, an indefinite delivery contract.
Was contract SPE2DR26FJZJ1 competed?
The extent of competition for SPE2DR26FJZJ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award